Sustained activation of c-jun-N-terminal kinase plays a critical role in arsenic trioxide-induced cell apoptosis in multiple myeloma cell lines.
about
The novel arsenical Darinaparsin circumvents BRG1-dependent, HO-1-mediated cytoprotection in leukemic cellsReactive oxygen species are not required for an arsenic trioxide-induced antioxidant response or apoptosisArsenic trioxide exerts antimyeloma effects by inhibiting activity in the cytoplasmic substrates of histone deacetylase 6Lidamycin shows highly potent cytotoxic to myeloma cells and inhibits tumor growth in miceIdentification of early growth response protein 1 (EGR-1) as a novel target for JUN-induced apoptosis in multiple myelomaArsenic trioxide downregulates specificity protein (Sp) transcription factors and inhibits bladder cancer cell and tumor growthThe oxidative stress response regulates DKK1 expression through the JNK signaling cascade in multiple myeloma plasma cellsBH3-only proteins Noxa, Bmf, and Bim are necessary for arsenic trioxide-induced cell death in myeloma.Arsenic trioxide-based therapy in relapsed/refractory multiple myeloma patients: a meta-analysis and systematic review.Poly(ADP-ribose) polymerase family member 14 (PARP14) is a novel effector of the JNK2-dependent pro-survival signal in multiple myeloma.Assessment of the involvement of oxidative stress and Mitogen-Activated Protein Kinase signaling pathways in the cytotoxic effects of arsenic trioxide and its combination with sulindac or its metabolites: sulindac sulfide and sulindac sulfone on humA novel arsenical has antitumor activity toward As2O3-resistant and MRP1/ABCC1-overexpressing cell lines.Potentiation of arsenic neurotoxicity by folate deprivation: protective role of S-adenosyl methionine.Effects of KGF on alveolar epithelial cell transdifferentiation are mediated by JNK signaling.
P2860
Q28285958-EFE64FEE-C4DC-490A-A876-E191B6248AABQ28388476-33EE6ED1-4537-4D11-856F-604AFAF65A64Q28481142-C633735E-A1AC-4CCA-97AC-4192FEBF0F3BQ33477869-64699F86-446B-421A-AE92-15D1B321F907Q33579526-E156AE0F-E8DA-4A83-914C-D9572EC9D127Q33976179-652BAE3C-F40C-4E64-ACA1-601A6FB71805Q35828711-3AAAB568-56CB-4D45-9A4B-110AB06AC27FQ36658048-E36A4B53-F8AE-44DB-8B3F-36083053CB33Q38253354-0A8651AA-E459-4C01-AB85-D4AD2D7FA4ACQ39264005-0DF59552-FDC9-4655-8A57-E92364CB9861Q39552261-B23F5C5D-6EAC-463C-8B78-F8048E442938Q39960419-CF782572-5620-4D32-A188-F1B7911C9C82Q40011614-5A25E8C4-6909-455C-8357-19EE5C4AD926Q41877597-2F2440F5-86B5-4493-98D7-D940AB5C8E53
P2860
Sustained activation of c-jun-N-terminal kinase plays a critical role in arsenic trioxide-induced cell apoptosis in multiple myeloma cell lines.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Sustained activation of c-jun- ...... n multiple myeloma cell lines.
@en
type
label
Sustained activation of c-jun- ...... n multiple myeloma cell lines.
@en
prefLabel
Sustained activation of c-jun- ...... n multiple myeloma cell lines.
@en
P2093
P2860
P1433
P1476
Sustained activation of c-jun- ...... n multiple myeloma cell lines.
@en
P2093
Kazuhito Yamamoto
Nobuhiko Emi
Ryuzo Ueda
Shinsuke Iida
Tomohiro Kajiguchi
Tomoki Naoe
P2860
P304
P356
10.1111/J.1349-7006.2006.00199.X
P577
2006-06-01T00:00:00Z